- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/182 - Radicals derived from carboxylic acids
Patent holdings for IPC class C07D 295/182
Total number of patents in this class: 58
10-year publication summary
|
4
|
3
|
2
|
3
|
2
|
5
|
2
|
3
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Newron Pharmaceuticals S.p.A. | 62 |
12 |
| AstraZeneca AB | 2897 |
2 |
| W. L. Gore & Associates, Inc. | 2710 |
2 |
| Dongguk University Industry-Academic Cooperation Foundation | 434 |
2 |
| Sunovion Pharmaceuticals Inc. | 263 |
2 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 32 |
2 |
| Nanjing Redwood Fine Chemical Co., Ltd | 2 |
2 |
| F. Hoffmann-La Roche AG | 7945 |
1 |
| Bayer Cropscience AG | 2038 |
1 |
| Agency for Science, Technology and Research | 3630 |
1 |
| Abide Therapeutics, Inc. | 26 |
1 |
| Ambrilia Biopharma Inc. | 4 |
1 |
| Catabasis Pharmaceuticals, Inc. | 36 |
1 |
| Cytokinetics, Inc. | 279 |
1 |
| Fudan University | 689 |
1 |
| Imago Biosciences, Inc. | 38 |
1 |
| Kraton Polymers U.S. LLC | 200 |
1 |
| Metabolys | 7 |
1 |
| Neuromed Pharmaceuticals Ltd. | 10 |
1 |
| NHWA Pharma. Corporation | 50 |
1 |
| Other owners | 21 |